{"doi":"10.1001/jamanetworkopen.2023.27351","title":"Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma","abstract":"Importance: Patients with mesothelioma often have next-generation sequencing (NGS) of their tumor performed; tumor-only NGS may incidentally identify germline pathogenic or likely pathogenic (P/LP) variants despite not being designed for this purpose. It is unknown how frequently patients with mesothelioma have germline P/LP variants incidentally detected via tumor-only NGS. Objective: To determine the prevalence of incidental germline P/LP variants detected via tumor-only NGS of mesothelioma. Design, Setting, and Participants: A series of 161 unrelated patients with mesothelioma from a high-volume mesothelioma program had tumor-only and germline NGS performed during April 2016 to October 2021. Follow-up ranged from 18 months to 7 years. Tumor and germline assays were compared to determine which P/LP variants identified via tumor-only NGS were of germline origin. Data were analyzed from January to March 2023. Main Outcomes and Measures: The proportion of patients with mesothelioma who had P/LP germline variants incidentally detected via tumor-only NGS. Results: Of 161 patients with mesothelioma, 105 were male (65%), the mean (SD) age was 64.7 (11.2) years, and 156 patients (97%) self-identified as non-Hispanic White. Most (126 patients [78%]) had at least 1 potentially incidental P/LP germline variant. The positive predictive value of a potentially incidental germline P/LP variant on tumor-only NGS was 20%. Overall, 26 patients (16%) carried a P/LP germline variant. Germline P/LP variants were identified in ATM, ATR, BAP1, CHEK2, DDX41, FANCM, HAX1, MRE11A, MSH6, MUTYH, NF1, SAMD9L, and TMEM127. Conclusions and Relevance: In this case series of 161 patients with mesothelioma, 16% had confirmed germline P/LP variants. Given the implications of a hereditary cancer syndrome diagnosis for preventive care and familial counseling, clinical approaches for addressing incidental P/LP germline variants in tumor-only NGS are needed. Tumor-only sequencing should not replace dedicated germline testing. Universal germline testing is likely needed for patients with mesothelioma.","journal":"JAMA Network Open","year":2023,"id":338684,"datarank":0.6297421366315477,"base_score":2.9444389791664403,"endowment":2.9444389791664403,"self_citation_contribution":0.44166584687496613,"citation_network_contribution":0.18807628975658158,"self_endowment_contribution":0.44166584687496613,"citer_contribution":0.18807628975658158,"corpus_percentile":null,"corpus_rank":null,"citation_count":18,"citer_count":13,"citers_with_citation_signal":8,"citers_with_endowment":8,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9603,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1012226,"name":"Katie Gilliam","orcid":null,"position":1,"is_corresponding":false},{"id":251701,"name":"Daniela del Gaudio","orcid":"0000-0001-8318-6055","position":2,"is_corresponding":false},{"id":851382,"name":"Kelsey E. McNeely","orcid":"0000-0002-8255-6816","position":3,"is_corresponding":false},{"id":1012227,"name":"Shaili Smith","orcid":null,"position":4,"is_corresponding":false},{"id":96381,"name":"Maria Acevedo","orcid":"0000-0002-5389-7961","position":5,"is_corresponding":false},{"id":1012228,"name":"Meghana Gaduraju","orcid":null,"position":6,"is_corresponding":false},{"id":1011704,"name":"Rachel Hodge","orcid":"0009-0009-3869-2835","position":7,"is_corresponding":false},{"id":1011705,"name":"Aubrianna Ramsland","orcid":"0009-0006-8637-6886","position":8,"is_corresponding":false},{"id":807924,"name":"Jeremy Segal","orcid":"0009-0006-8707-7140","position":9,"is_corresponding":false},{"id":63090,"name":"Soma Das","orcid":"0000-0003-0387-6801","position":10,"is_corresponding":false},{"id":1071595,"name":"Feighanne Hathaway","orcid":"0009-0007-3648-6427","position":11,"is_corresponding":false},{"id":1011707,"name":"Darren S. Bryan","orcid":"0000-0003-1447-8323","position":12,"is_corresponding":false},{"id":1012229,"name":"Sanjukta Tawde","orcid":null,"position":13,"is_corresponding":false},{"id":1012230,"name":"Shelly Galasinski","orcid":null,"position":14,"is_corresponding":false},{"id":979067,"name":"Peng Wang","orcid":"0000-0003-4303-6081","position":15,"is_corresponding":false},{"id":1011708,"name":"Melissa Y. Tjota","orcid":"0000-0002-5869-3175","position":16,"is_corresponding":false},{"id":314880,"name":"Aliya N. Husain","orcid":"0000-0001-5492-7387","position":17,"is_corresponding":false},{"id":509692,"name":"Samuel G. Armato","orcid":"0000-0002-5428-7997","position":18,"is_corresponding":false},{"id":553710,"name":"Jessica Donington","orcid":"0000-0003-3760-7327","position":19,"is_corresponding":false},{"id":581536,"name":"Mark K. Ferguson","orcid":"0000-0001-6651-7668","position":20,"is_corresponding":false},{"id":308191,"name":"Kiran K. Turaga","orcid":"0000-0001-8541-586X","position":21,"is_corresponding":false},{"id":561561,"name":"Jane E. Churpek","orcid":"0000-0001-7998-5479","position":22,"is_corresponding":false},{"id":308196,"name":"Hedy L. Kindler","orcid":"0000-0002-5450-842X","position":23,"is_corresponding":false},{"id":660472,"name":"Michael W. Drazer","orcid":"0000-0002-8171-4106","position":24,"is_corresponding":false},{"id":771761,"name":"Owen Mitchell","orcid":"0000-0001-5601-731X","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T01:10:40.496978Z","pmid":"37556141","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}